Total: $111.95M

Company
(Symbol)#

Type Of Financing

Number Of Shares, Units
Or Warrants (M)

Amount Raised
(M)

Investors; Placement Agents; Details
(Date)@

AlphaRx Inc. (Canada; OTC BB:ALRX)

Private placement of common stock

3.5S

US$4.6

AlphaRx raised US$4.6M in a private placement of 3.5M common shares at 18.5 cents apiece; for each share purchased, the subscriber is receiving two warrants to purchase an additional share at 37 cents (5/10)

Bioenvision Inc. (OTC BB: BIOV)

Private placement of common stock and warrants

N/A

$17.75

Bioenvision raised $17.75M in a private placement (5/21)

Biopure Corp. (BPUR)

Private placement of common stock

0.69S

$5.18

Biopure raised $5.18M in a private placement with institutional investors (5/8)

CollaGenex Pharmaceuticals
Inc. (CGPI)

Private placement of common stock

0.119S

$1

CollaGenex placed 119,335 shares with Kingsbridge Capital Ltd., raising $1M (5/30)

Deltagen Inc. (DGEN)

Private placement of common stock

5.54S

$25.3

Deltagen raised $25.3M in a private placement of 5.54M shares; investors were Alta Partners, the Sprout Group, Cooper Hill Partners LLC, Tang Family Funds, Cranshire Capital, Castle Creek, Mikels Miller and Acqua Wellington (5/16)

Genetronics Biomedical Corp. (AMEX:GEB)

Private placement of special warrants

N/A

$3.3

Genetronics raised $3.3M in the private placement of special warrants issued at 42 cents per warrant (5/23)

Marshall Edwards Inc. (AIM:MSH; subsidiary of
Novogen Ltd; Australia; NVGN)

Private placement of common stock

N/A

$10.1

Marshall Edwards raised $10.1M in an initial private placement from unnamed European, American and Australian investors and institutions (5/22)

Onyx Pharmaceuticals Inc. (ONXX)

Private placement of common stock and warrants

2.97S and W for 0.74S

$20

Onyx raised $20M in a private placement; investors were Domain Associates LLC, OrbiMed Advisors LLC, Perceptive Life Sciences Fund and Federated Kaufmann Fund, as well as other investors (5/9)

Ortec International Inc. (ORTC)

Private placement of secured convertible debentures

N/A

$2.3

Ortec secured $2.3M in a financing through the sale of 12-month secured convertible debentures to new and existing investors; H.C. Wainwright & Co. Inc. acted as financial adviser and placement agent (5/7)

Osteotech Inc. (OSTE)

Private placement of common stock

2.8S

$17.5

Osteotech raised $17.5M in a private financing with a group of institutional investors (5/9)

Procyon Biopharma Inc. (Canada; TSE:PBP)

Private placement of units

1U

C$1.45
(US$0.92)

Procyon raised US$0.92M in a private placement done concurrent with a US$5.5M public offering (5/8)

The Immune Response Corp. (IMNR)

Private placement of a convertible note and warrant

W for 9.28S

$4

Company privately placed a $4M convertible note and warrant with Oshkim Ltd. Partnership (5/7)

Notes:

This chart does not include real estate or manufacturing plant financings.

# Unless otherwise indicated, shares are traded on the Nasdaq exchange.

@ Dates refer to the date of the press release.

N/A = Not available, applicable or reported.

AIM =Alternative Investment Market of the London Stock Exchange; AMEX = American Stock Exchange; OTC BB = Over the Counter Bulletin Board; TSE = Toronto Stock Exchange